| 000 | 02537 a2200649 4500 | ||
|---|---|---|---|
| 005 | 20250515075157.0 | ||
| 264 | 0 | _c20071025 | |
| 008 | 200710s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/j.ejphar.2007.05.046 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBhuiyan, Md Shenuarin | |
| 245 | 0 | 0 |
_aCytoprotective effect of bis(1-oxy-2-pyridinethiolato)oxovanadiun(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cOct 2007 |
||
| 300 |
_a180-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xmetabolism |
| 650 | 0 | 4 | _aBcl-2-Like Protein 11 |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCASP8 and FADD-Like Apoptosis Regulating Protein _xmetabolism |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
| 650 | 0 | 4 | _aCaspase Inhibitors |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 |
_aCoronary Vessels _xsurgery |
| 650 | 0 | 4 | _aCytoprotection |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFas Ligand Protein _xmetabolism |
| 650 | 0 | 4 |
_aForkhead Transcription Factors _xmetabolism |
| 650 | 0 | 4 | _aLigation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Proteins _xmetabolism |
| 650 | 0 | 4 |
_aMyocardial Infarction _xetiology |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xcomplications |
| 650 | 0 | 4 |
_aMyocardial Reperfusion Injury _xetiology |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xpharmacology |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
| 650 | 0 | 4 |
_aVentricular Pressure _xdrug effects |
| 650 | 0 | 4 |
_abcl-Associated Death Protein _xmetabolism |
| 700 | 1 | _aShibuya, Masatoshi | |
| 700 | 1 | _aShioda, Norifumi | |
| 700 | 1 | _aMoriguchi, Shigeki | |
| 700 | 1 | _aKasahara, Jiro | |
| 700 | 1 | _aIwabuchi, Yosiharu | |
| 700 | 1 | _aFukunaga, Kohji | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 571 _gno. 2-3 _gp. 180-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2007.05.046 _zAvailable from publisher's website |
| 999 |
_c17191992 _d17191992 |
||